The Need for Ready-To-Administer Solutions in Acute Care
Several factors motivate pharmaceutical companies and hospitals to use glass prefillable syringes (PFS) for Intravenous (IV) applications. By switching from vials and ampules to a glass PFS, hospitals have the potential to reduce medical errors, improve workflow efficiency and impact ROI for hospital stakeholders.
Moreover, data suggests that approximately 92% of hospital stakeholders are willing to use prefilled syringes for multiple drugs.
For pharmaceutical companies, transitioning a fixed-dose drug from its vial or ampule format to a prefilled syringe can serve as a differentiation strategy in a market dominated by vials and ampules.
This session will examine the benefits and challenges associated with glass formats, and will explore BD’s glass prefillable syringe with connection performance verified for IV applications.
Sagar Bejalwar, Global Portfolio Lead - Acute care & Specialty, BD Medical Pharmaceutical Systems